MRI Useful for Predicting Failure of Metal-on-Metal Hip Implants
Newswise — Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in an upcoming issue of the Journal of Bone & Joint Surgery, demonstrates that MRI can be used to identify implants that are going to fail before people become symptomatic.
“The study shows that synovitis exists in asymptomatic people in a fairly high prevalence,” said Hollis Potter, M.D., chief of the Division of Magnetic Resonance Imaging at Hospital for Special Surgery, in New York City. “If that is the case, symptoms alone are insufficient to determine the health of an implant. You can’t wait for people to be sore before we evaluate them for this potential problem.” The researchers say that MRIs can help identify patients who need revision surgery before tissue sustains further damage that makes a revision more difficult.
Hip resurfacing, a surgical alternative to total hip replacement (THR), involves placing a metal cap over the head of the femur while a matching metal cup, similar to that used in a THR, is placed in the pelvic socket. The procedure preserves more of a patient’s thigh bone than a conventional hip replacement, but the implants can cause synovitis. Until now, no objective data has existed regarding just how much inflammation these implants can cause. To fill this knowledge gap, investigators set out to evaluate the ability of MRI to detect and quantify adverse synovial responses in symptomatic and asymptomatic subjects following metal-on-metal hip resurfacing.
The investigators included the first 69 consecutive subjects (74 hips) referred from three surgical practices to the Hospital for Special Surgery for an MRI after a metal-on-metal hip resurfacing arthroplasty. Patients were classified as asymptomatic, having unexplained pain, or symptomatic with a mechanical cause. This latter category included patients with pain caused by implant loosening, dislocation, periprosthetic fracture, or original faulty positioning of the implant.
All individuals underwent an MRI and then these scans were evaluated by two musculoskeletal radiologists, both of whom were blinded as to which group the patient belonged to. X-rays were also obtained for most patients. Wear of metal-on-metal implant surfaces produces metal wear debris in the form of very small microscopic particles, resulting in metal ion release, which may impact local tissue and other body systems. Therefore, serum cobalt and chromium ion levels measured closest to the date of the MRI were recorded when available. Investigators also collected demographic data, including age, sex, body-mass index, and length of time since arthroplasty.
Analysis of the MRIs identified synovitis in 68% of asymptomatic hips, 75% of symptomatic hips with a mechanical cause, and 78% of hips with unexplained pain. “What was really interesting about this study was that we found that synovitis was detected in the same amount in symptomatic and asymptomatic patients,” said Dr. Potter.
The average volume of synovitis was 5.0 cm3 in the asymptomatic group, 10.2 cm3 in the mechanical causes group, and 31.0 cm3 in the unexplained pain group. “The data show that there is a high prevalence of abnormal synovial response in both symptomatic and highly functioning, asymptomatic patients who have undergone metal-on-metal arthroplasty, indicating that symptoms alone are insufficient means by which to monitor patients,” Dr. Potter said.
There were no significant differences in the X-rays or serum ion levels, demonstrating that these could not be used to predict damage. “Many people focus on serum ion levels,” said Dr. Potter. “I think the direction of the pendulum is really changing now, away from serum ion levels and toward imaging, or at least not to focus so much on serum ion levels to predict potential damage. Cross sectional imaging is the way to go, and specifically, MRI over CT based on its superior soft tissue contrast.”
Other Hospital for Special Surgery investigators involved in the study include the lead author, Danyal Nawabi, M.D.; Catherine Hayter, MBBS; Edwin Su, M.D.; Mathew Koff, Ph.D.; Giorgio Perino, M.D.; and Stephanie Gold, B.A. Kevin Koch, Ph.D., from General Electric (GE) Healthcare also participated in the study, and GE Healthcare provided funding for the scanning of asymptomatic subjects.
About Hospital for Special SurgeryFounded in 1863, Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked No. 1 in orthopedics, No. 3 in rheumatology, No. 10 in neurology and No. 5 in geriatrics by U.S. News & World Report (2012-13), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center three consecutive times. HSS has one of the lowest infection rates in the country. From 2007 to 2011, HSS has been a recipient of the HealthGrades Joint Replacement Excellence Award. HSS is a member of the NewYork-Presbyterian Healthcare System and an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City and online at www.hss.edu.